Bluejay Diagnostics, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | $-6.8M | $-7.7M | $-10.0M | $-9.3M | $-3.5M | $-1.2M |
| Depreciation & Amortization | — | — | — | $156.6K | $145.7K | $157.0K |
| Depreciation | $74.2K | $75.6K | $648.7K | $156.6K | — | — |
| Amortization | — | — | — | — | — | — |
| Stock-Based Compensation | $6 | $20.1K | $189.2K | $433.0K | $68.5K | $3.7K |
| Net Cash from Operating Activities | $-6.1M | $-7.8M | $-8.3M | $-7.7M | $-4.4M | $-508.7K |
| Investing Activities | ||||||
| Capital Expenditures | $173.7K | $306.8K | $704.2K | $1.2M | $23.9K | — |
| Business Acquisitions | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-173.7K | $-306.8K | $-704.2K | $-1.2M | $-23.9K | — |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — |
| Net Cash from Financing Activities | $7.1M | $10.2M | $1.1M | $8.1K | $22.5M | $1.3M |
| Net Change in Cash | — | — | — | $-8.9M | $18.1M | $816.4K |
| Free Cash Flow | $-6.2M | $-8.1M | $-9.0M | $-8.9M | $-4.4M | — |